List of Tables
Table 1. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (2020-2025) & (K Units)
Table 8. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Share by Manufacturers (2020-2025)
Table 12. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Equine Chorionic Gonadotropin (eCG) for Injection by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Chorionic Gonadotropin (eCG) for Injection as of 2024)
Table 16. Global Equine Chorionic Gonadotropin (eCG) for Injection Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Equine Chorionic Gonadotropin (eCG) for Injection Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base and Headquarters
Table 19. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2020-2025) & (K Units)
Table 23. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Type (2026-2031) & (K Units)
Table 24. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Equine Chorionic Gonadotropin (eCG) for Injection ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2020-2025) & (K Units)
Table 29. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales by Application (2026-2031) & (K Units)
Table 30. Equine Chorionic Gonadotropin (eCG) for Injection High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Equine Chorionic Gonadotropin (eCG) for Injection ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Equine Chorionic Gonadotropin (eCG) for Injection Growth Accelerators and Market Barriers
Table 37. North America Equine Chorionic Gonadotropin (eCG) for Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Equine Chorionic Gonadotropin (eCG) for Injection Growth Accelerators and Market Barriers
Table 40. Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Equine Chorionic Gonadotropin (eCG) for Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Equine Chorionic Gonadotropin (eCG) for Injection Growth Accelerators and Market Barriers
Table 45. Southeast Asia Equine Chorionic Gonadotropin (eCG) for Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Equine Chorionic Gonadotropin (eCG) for Injection Investment Opportunities and Key Challenges
Table 47. Central and South America Equine Chorionic Gonadotropin (eCG) for Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. MSD Animal Health Corporation Information
Table 51. MSD Animal Health Description and Major Businesses
Table 52. MSD Animal Health Product Models, Descriptions and Specifications
Table 53. MSD Animal Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. MSD Animal Health Sales Value Proportion by Product in 2024
Table 55. MSD Animal Health Sales Value Proportion by Application in 2024
Table 56. MSD Animal Health Sales Value Proportion by Geographic Area in 2024
Table 57. MSD Animal Health Equine Chorionic Gonadotropin (eCG) for Injection SWOT Analysis
Table 58. MSD Animal Health Recent Developments
Table 59. Ceva Santé Animale Corporation Information
Table 60. Ceva Santé Animale Description and Major Businesses
Table 61. Ceva Santé Animale Product Models, Descriptions and Specifications
Table 62. Ceva Santé Animale Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Ceva Santé Animale Sales Value Proportion by Product in 2024
Table 64. Ceva Santé Animale Sales Value Proportion by Application in 2024
Table 65. Ceva Santé Animale Sales Value Proportion by Geographic Area in 2024
Table 66. Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) for Injection SWOT Analysis
Table 67. Ceva Santé Animale Recent Developments
Table 68. Syntex SA Corporation Information
Table 69. Syntex SA Description and Major Businesses
Table 70. Syntex SA Product Models, Descriptions and Specifications
Table 71. Syntex SA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Syntex SA Sales Value Proportion by Product in 2024
Table 73. Syntex SA Sales Value Proportion by Application in 2024
Table 74. Syntex SA Sales Value Proportion by Geographic Area in 2024
Table 75. Syntex SA Equine Chorionic Gonadotropin (eCG) for Injection SWOT Analysis
Table 76. Syntex SA Recent Developments
Table 77. Bioveta Corporation Information
Table 78. Bioveta Description and Major Businesses
Table 79. Bioveta Product Models, Descriptions and Specifications
Table 80. Bioveta Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Bioveta Sales Value Proportion by Product in 2024
Table 82. Bioveta Sales Value Proportion by Application in 2024
Table 83. Bioveta Sales Value Proportion by Geographic Area in 2024
Table 84. Bioveta Equine Chorionic Gonadotropin (eCG) for Injection SWOT Analysis
Table 85. Bioveta Recent Developments
Table 86. Ningbo Sansheng Biological Technology Corporation Information
Table 87. Ningbo Sansheng Biological Technology Description and Major Businesses
Table 88. Ningbo Sansheng Biological Technology Product Models, Descriptions and Specifications
Table 89. Ningbo Sansheng Biological Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Ningbo Sansheng Biological Technology Sales Value Proportion by Product in 2024
Table 91. Ningbo Sansheng Biological Technology Sales Value Proportion by Application in 2024
Table 92. Ningbo Sansheng Biological Technology Sales Value Proportion by Geographic Area in 2024
Table 93. Ningbo Sansheng Biological Technology Equine Chorionic Gonadotropin (eCG) for Injection SWOT Analysis
Table 94. Ningbo Sansheng Biological Technology Recent Developments
Table 95. Ningbo Second Hormone Factory Corporation Information
Table 96. Ningbo Second Hormone Factory Description and Major Businesses
Table 97. Ningbo Second Hormone Factory Product Models, Descriptions and Specifications
Table 98. Ningbo Second Hormone Factory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Ningbo Second Hormone Factory Recent Developments
Table 100. Chifeng Bo-en Pharmaceutical Corporation Information
Table 101. Chifeng Bo-en Pharmaceutical Description and Major Businesses
Table 102. Chifeng Bo-en Pharmaceutical Product Models, Descriptions and Specifications
Table 103. Chifeng Bo-en Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Chifeng Bo-en Pharmaceutical Recent Developments
Table 105. Guangzhou Vbio-Pharma Corporation Information
Table 106. Guangzhou Vbio-Pharma Description and Major Businesses
Table 107. Guangzhou Vbio-Pharma Product Models, Descriptions and Specifications
Table 108. Guangzhou Vbio-Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Guangzhou Vbio-Pharma Recent Developments
Table 110. JALLY Corporation Information
Table 111. JALLY Description and Major Businesses
Table 112. JALLY Product Models, Descriptions and Specifications
Table 113. JALLY Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. JALLY Recent Developments
Table 115. Ningbo Creator Animal Pharmaceutical Corporation Information
Table 116. Ningbo Creator Animal Pharmaceutical Description and Major Businesses
Table 117. Ningbo Creator Animal Pharmaceutical Product Models, Descriptions and Specifications
Table 118. Ningbo Creator Animal Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Ningbo Creator Animal Pharmaceutical Recent Developments
Table 120. Key Raw Materials Distribution
Table 121. Raw Materials Key Suppliers
Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 123. Milestones in Production Technology Evolution
Table 124. Distributors List
Table 125. Market Trends and Market Evolution
Table 126. Market Drivers and Opportunities
Table 127. Market Challenges, Risks, and Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Equine Chorionic Gonadotropin (eCG) for Injection Product Picture
Figure 2. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 1000 IU/Unit Product Picture
Figure 4. 5000 IU/Unit Product Picture
Figure 5. Others Product Picture
Figure 6. Global Equine Chorionic Gonadotropin (eCG) for Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Pig
Figure 8. Cattle
Figure 9. Sheep
Figure 10. Horse
Figure 11. Other Animals
Figure 12. Equine Chorionic Gonadotropin (eCG) for Injection Report Years Considered
Figure 13. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2031) & (US$ Million)
Figure 15. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Region (2020-2031)
Figure 17. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (2020-2031) & (K Units)
Figure 18. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales (CAGR) by Region (2020-2031) (K Units)
Figure 19. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers Equine Chorionic Gonadotropin (eCG) for Injection Sales Volume Market Share in 2024
Figure 21. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. 1000 IU/Unit Revenue Market Share by Manufacturer in 2024
Figure 24. 5000 IU/Unit Revenue Market Share by Manufacturer in 2024
Figure 25. Others Revenue Market Share by Manufacturer in 2024
Figure 26. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Type (2020-2031)
Figure 27. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Type (2020-2031)
Figure 28. Global Equine Chorionic Gonadotropin (eCG) for Injection Sales Market Share by Application (2020-2031)
Figure 29. Global Equine Chorionic Gonadotropin (eCG) for Injection Revenue Market Share by Application (2020-2031)
Figure 30. North America Equine Chorionic Gonadotropin (eCG) for Injection Sales YoY (2020-2031) & (K Units)
Figure 31. North America Equine Chorionic Gonadotropin (eCG) for Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 32. North America Top 5 Manufacturers Equine Chorionic Gonadotropin (eCG) for Injection Sales Revenue (US$ Million) in 2024
Figure 33. North America Equine Chorionic Gonadotropin (eCG) for Injection Sales Volume (K Units) by Type (2020- 2031)
Figure 34. North America Equine Chorionic Gonadotropin (eCG) for Injection Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 35. North America Equine Chorionic Gonadotropin (eCG) for Injection Sales Volume (K Units) by Application (2020-2031)
Figure 36. North America Equine Chorionic Gonadotropin (eCG) for Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 37. US Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2031) & (US$ Million)
Figure 38. Canada Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2031) & (US$ Million)
Figure 39. Mexico Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2031) & (US$ Million)
Figure 40. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales YoY (2020-2031) & (K Units)
Figure 41. Europe Equine Chorionic Gonadotropin (eCG) for Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 42. Europe Top 5 Manufacturers Equine Chorionic Gonadotropin (eCG) for Injection Sales Revenue (US$ Million) in 2024
Figure 43. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales Volume (K Units) by Type (2020-2031)
Figure 44. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales Revenue (US$ Million) by Type (2020-2031)
Figure 45. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales Volume (K Units) by Application (2020-2031)
Figure 46. Europe Equine Chorionic Gonadotropin (eCG) for Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 47. Germany Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2031) & (US$ Million)
Figure 48. France Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2031) & (US$ Million)
Figure 49. U.K. Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2031) & (US$ Million)
Figure 50. Italy Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2031) & (US$ Million)
Figure 51. Russia Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales YoY (2020-2031) & (K Units)
Figure 53. Asia-Pacific Equine Chorionic Gonadotropin (eCG) for Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Top 8 Manufacturers Equine Chorionic Gonadotropin (eCG) for Injection Sales Revenue (US$ Million) in 2024
Figure 55. Asia-Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales Volume (K Units) by Type (2020- 2031)
Figure 56. Asia-Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 57. Asia-Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales Volume (K Units) by Application (2020-2031)
Figure 58. Asia-Pacific Equine Chorionic Gonadotropin (eCG) for Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 59. Indonesia Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2031) & (US$ Million)
Figure 60. Japan Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2031) & (US$ Million)
Figure 61. South Korea Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2031) & (US$ Million)
Figure 62. China Taiwan Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2031) & (US$ Million)
Figure 63. India Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2031) & (US$ Million)
Figure 64. Central and South America Equine Chorionic Gonadotropin (eCG) for Injection Sales YoY (2020-2031) & (K Units)
Figure 65. Central and South America Equine Chorionic Gonadotropin (eCG) for Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Central and South America Top 5 Manufacturers Equine Chorionic Gonadotropin (eCG) for Injection Sales Revenue (US$ Million) in 2024
Figure 67. Central and South America Equine Chorionic Gonadotropin (eCG) for Injection Sales Volume (K Units) by Type (2021-2031)
Figure 68. Central and South America Equine Chorionic Gonadotropin (eCG) for Injection Sales Revenue (US$ Million) by Type (2020-2031)
Figure 69. Central and South America Equine Chorionic Gonadotropin (eCG) for Injection Sales Volume (K Units) by Application (2020-2031)
Figure 70. Central and South America Equine Chorionic Gonadotropin (eCG) for Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 71. Brazil Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2025) & (US$ Million)
Figure 72. Argentina Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2025) & (US$ Million)
Figure 73. Middle East, and Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales YoY (2020-2031) & (K Units)
Figure 74. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Middle East and Africa Top 5 Manufacturers Equine Chorionic Gonadotropin (eCG) for Injection Sales Revenue (US$ Million) in 2024
Figure 76. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales Volume (K Units) by Type (2021-2031)
Figure 77. South America Equine Chorionic Gonadotropin (eCG) for Injection Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales Volume (K Units) by Application (2020-2031)
Figure 79. Middle East and Africa Equine Chorionic Gonadotropin (eCG) for Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. GCC Countries Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2025) & (US$ Million)
Figure 81. Turkey Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2025) & (US$ Million)
Figure 82. Egypt Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2025) & (US$ Million)
Figure 83. South Africa Equine Chorionic Gonadotropin (eCG) for Injection Revenue (2020-2025) & (US$ Million)
Figure 84. Equine Chorionic Gonadotropin (eCG) for Injection Industry Chain Mapping
Figure 85. Regional Equine Chorionic Gonadotropin (eCG) for Injection Manufacturing Base Distribution (%)
Figure 86. Global Equine Chorionic Gonadotropin (eCG) for Injection Production Market Share by Region (2020-2031)
Figure 87. Equine Chorionic Gonadotropin (eCG) for Injection Production Process
Figure 88. Regional Equine Chorionic Gonadotropin (eCG) for Injection Production Cost Structure
Figure 89. Channels of Distribution (Direct Vs Distribution)
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed
